. —— the vaccines from astrazeneca. —— the eu demands the vaccines. where the eu has asked that the astrazeneca release for details, the confidentiality clause they signed between the eu and the company, to release the details. it's pretty much getting quite messy. there was a stranue much getting quite messy. there was a strange situation _ much getting quite messy. there was a strange situation today _ much getting quite messy. there was a strange situation today where - a strange situation today where there _ a strange situation today where there was— a strange situation today where there was talk of whether astrazeneca was coming to the table for the _ astrazeneca was coming to the table for the eu _ astrazeneca was coming to the table for the eu meeting. astrazeneca was coming to the table forthe eu meeting. there has been this talk— forthe eu meeting. there has been this talk about best efforts which for many— this talk about best efforts which for many of us in other roles we do, the tegatese — for many of us in other roles we do, the legalese

the astrazeneca vaccine means that astrazeneca will continue _ vaccine means that astrazeneca will continueinclude the information from all the studies, information from other regulators, and very importantly reports — regulators, and very importantly reports of — regulators, and very importantly reports of suspected side—effects from _ reports of suspected side—effects from people who have received vaccination as well as the health care professionals. will vaccination as well as the health care professionals.— vaccination as well as the health care professionals. will leave that news briefing _ care professionals. will leave that news briefing in _ care professionals. will leave that news briefing in amsterdam - care professionals. will leave that news briefing in amsterdam for. care professionals. will leave that. news briefing in amsterdam for now, but to give you the key elements from that the european medicines agency has indeed given the go—ahead for the chap to be used across the eu for everyone over the age of 18. let's bring you one key paragraph as well that was talked about there

continues with the eumpean _ astrazeneca vaccine continues with the european union _ astrazenecaaccine continues with the european union and also - astrazeneca vaccine continues with i the european union and also germany casting doubt on whether it is really that effective for people over 65. why is their view so different from the uk? n over 65. why is their view so different from the uk? i suspect there is a little _ different from the uk? i suspect there is a little bit _ different from the uk? i suspect there is a little bit of— different from the uk? i suspect there is a little bit of what - different from the uk? i suspect there is a little bit of what some j there is a little bit of what some might describe as vaccine nationalism going on here. the german vaccine advisory committee, because all countries have their own vaccine advisory committees, have taken a different view from the uk's, which is called thejcvi, and they say because they are right to point out there's very little effectiveness dative and older people, they would rather it was not, now, used in those aged

it comes amid a supply dispute between the eu and two major vaccine suppliers, astrazeneca and pfizere european commission says export controls are necessary to ensure that all eu citizens had access to vaccines. nick beake reports from brussels. throughout the week, this post—brexit battle between the eu and a british—based vaccine—maker has been intensifying. european countries are demanding that astrazeneca delivers all the jabs they ordered, even if it means taking them from the uk supply. it all hangs on the contract the two sides signed that's now been released, although with parts blanked out. astrazeneca says it agreed to do its reasonable best. the eu insists it was a legally—binding promise. and so it's now announced if it doesn't get what it ordered, it could block covid vaccines leaving europe heading for some countries, including the uk. we have to be very clear, and we have said it many times before. we are not protecting ourselves against any specific country, and we're not in competition or in a race against any country. the only race we're in is against this virus. at

the oxford—astrazeneca vaccine can be stored in a fridge. t minus 70. it will also play a key role in the global immunisation. three billion doses are set to be distributed worldwide this year. our medical editor, fergus walsh, joins me now. i suppose the big question, fergus, what is the timetable for vaccination, how many people in what kind of time? there are 31 million people, huw, in the vaccine priority groups, and the government have said tonight that it intends to offer a first dose tonight that it intends to offer a first do: still an extremely but it is still an extremely ambitious target, 2 million people a week for the next six weeks. now, everything will have to go really smoothly, because each batch of the vaccine, with pfizer or the astrazeneca oxford vaccine, has to pass quality controls, they should be 1000 vaccination centres set up across the uk by the end of the week. now, boris johnson across the uk by the end of the week. now, borisjohnson has said tonight that the uk has carried out more covid immunisation than the rest

the european union, which is struggling with a shortage of vaccine, has asked astrazeneca if it can divertupplies from britain. the prime minister visits a vaccine laboratory near edinburgh — he calls arguments about a scottish independence referendum "completely irrelevant" while the uk battles coronavirus. we'll be asking how worried the government is about the state of the union. also tonight... in prison afterflying home from medical treatment in germany — russia's opposition leader, alexei navalny, calls his detention illegal as a court rejects an appeal against his arrest. the cladding crisis — the woman who lost everything after buying a flat that turned out to be unsafe. and get your skates on — the new lockdown craze sweeping the globe. and coming up on bbc news... it's been the most thrilling finish in years — after 28,000 miles and 80 days of racing, frenchmen, yannick bestaven, wins the round—the—world solo yacht race, the vendee globe. good evening and welcome to the bbc news at six. the government says vaccine supplies won't be interrupted, despite a continuing row between as

too many, the oxford—astrazeneca vaccine is seen as a game oxford—astrazeneca vaccine is seen as a gamecoronavirus. it's cheaper than the buyers are bion tech jab and doesn't require super cold storage which makes it easier to transport, particularly those living in care homes. the uk has ordered an hundred million oxford—astrazeneca doses. from today, more than 500,000 will be delivered at a small group of hospitals before expanding toa of hospitals before expanding to a thousand centres by the end of the week. i hear particularly from a general practice colleagues up and down the country that they are raring to go. they are really, really busy but they also know this is the best thing they can do to protect their patients. so as supply allows, more sites will be able to offer the vaccine and that's exactly what we need to aim for. a million people have already received the pfizer vaccine but there are 30 million more in the priority groups, including frontline health workers and adults aged over 50. rapid delivery is vital so as part of its biggest homeland operation in peacetime, mem

vaccine. so what is the solution to all this? if astrazenecahaving problems producing the amount of vaccines that the european union says it is legally contracted to get, what's the way out of this? i think ultimately, what we're seeing is the death of trust between multinational pharmaceutical companies and the european union over the pressure and the dark reality, which you've seen yourself, of people dying waiting for the vaccine in countries like spain, where the vaccine is now postponed two weeks. and that trust has seen inspectors going to the premises here in belgium, of astrazeneca, because the eu commission didn't believe the reason given that they were having low production at the belgian plant. the suspicion was they were basically shorting the eu and selling some of that product to the uk. that's what's going on underneath this. i think the solution is that the trust has to build between the manufacturers in the eu. and also between countries — and that doesn't look good at the moment where i'm standing. the eu didn't want to get in

the uk was ahead of the curve when it came to signing deals for the astrazeneca vaccine and they werecurve when it came to approving this particular vaccine. on the flip side, we are seeing that unless all countries get on top of covid—i9, it is still a danger to all of us. what do you make of where we are with this particular aspect of the vaccine situation? i particular aspect of the vaccine situation? ~ , particular aspect of the vaccine situation? ~' , ., particular aspect of the vaccine situation?— particular aspect of the vaccine situation? ~' , ., , ~ , situation? i think will be a sink is a microcosm _ situation? i think will be a sink is a microcosm of _ situation? i think will be a sink is a microcosm of what _ situation? i think will be a sink is a microcosm of what it _ situation? i think will be a sink is a microcosm of what it looks - situation? i think will be a sink is a microcosm of what it looks like j a microcosm of what it looks like around the world. in some cases, just to put this in perspective, we are talking in the eu and the uk or the us of how many days or h

so now we've got the two mrna vaccines, we have the astrazeneca—oxford vaccine, we will hear thej&j vaccineavax, we have a recombinant and protein vaccine. and some people may ask why you need all these vaccines, well, there's limits in the capacity for production for any one of them, so the more we have the more shots on goal, the better globally we have a chance to beat this pandemic. and then in terms of the variants, where are we up to with knowing how much protection existing vaccines will provide against, for example, the variant that has been found in brazil and the one that has been found in south africa? yeah, the south african one is really worrying people because we are seeing diminished protection with both the pfizer and moderna mrna vaccine and we heard about the result today from the novavax vaccine which probably gives the highest virus neutralising antibody titres, which is kind of a surrogate marker or the protection of any of the vaccines and that is only doing 50—60%. so the real worry i'm thinking about, because we also have a recombinant protein vaccine and we are look

the oxford astrazeneca vaccine has an overall efficacy of 70% depending on the schedule of doses. een approved by the eu. russia's sputnik vaccine has a 94.1% efficacy, according to the manufacturer. it has emergency clearance in 15 nations. and china bs vaccine has been cleared in six countries. -- and china's vaccine has been cleared in six countries. it's mainly wealthier nations that are getting these vaccines and that concerns the world health organization. thwho has called on countries to think about the less religious. >> they are at the end of the queue right now. the people at the top of the queue are fighting about where they are in the queue, they are fighting over this. we need to step back and reflect on our colleagues and where they stand today and what we are going to do about that. anchor: let's talk to ellen marriott, an advisor. it would be good if there was uality in vaccine rollout, but if anything, the row between the eu and these major vaccine producers show there is not much equality right now, is there? >> know, and they are at the heart -- no, and at the he

and i believe a of it may depend on having the astrazeneca 0xford vaccine as soon as possible. as possible.— soon as possible. 0k. very briefl , soon as possible. 0k. very briefly, we're _ soon as possible. 0k. very briefly, we're almost - soon as possible. 0k. very briefly, we're almost out . soon as possible. 0k. very| briefly, we're almost out of time, given rows we are seeing about which countries in which areas are getting the vaccines when supplies are being held up, do you think this now needs to be done on an international scale? does they need to be one body overseeing the allocation of vaccines for all countries? the problem now is in the last year we have had this breakdown in the global governance of vaccines, despite best efforts by garvey and the gates foundation and others to put this sharing facility together, how you now walk this back to restore international governance in light of the breakdowns and including the us that declared eminent domain over a loss of vaccines and then what russia did angina with what people are now falling vaccine nationalism, how yo

today, the european regulars on vaccines approve the astrazeneca vaccine _ vaccines approve the astrazenecan the european regulator. he did reference an emphasis on the over 65, but it said that _ an emphasis on the over 65, but it said that the other vaccines do work in over— said that the other vaccines do work in over 60 _ said that the other vaccines do work in over 60 fives and it was not a concern — in over 60 fives and it was not a concern that it did not work, sol think— concern that it did not work, sol think it _ concern that it did not work, sol think it was _ concern that it did not work, sol think it was a general scientific belief— think it was a general scientific belief that vaccines can lose effectiveness and the order generations but not that they do not work -- _ generations but not that they do not work -- the — generations but not that they do not work —— the over—655. to come out on the record _ work —— the over—655. to come out on the record and — work —— the over—655. to come out on the record and say it does not work, that might _ the record and say it does not work

the european commission has approved astrazeneca's vaccine for use across the eu. brussels signed off on the use of the vaccine in people over the age of 18. the eu is facing sour criticism for the slow pace of its vaccine rollout. astrazeneca is the third to gain approval. stricter brussels -- straight to brussels where we find correspondent teri schultz. millions in the u.k. have already received the vaccine. why has the eu been so slow look? -- so slow? terry: that's right. the eu medical agency is not in the business of applying -- of apologizing for taking whatever time takes -- for taking whatever time it deems necessary. it was the first one they started looking to approve but it was the most complex. they simply said they are working as fast as they can to get results, and they cannot be sped up by pressure. phil: meanwhile, german and french elk officials have questioned the drug's efficacy in people over 60. what has the ema said about this age group? terry: that's right. ema did talk about this today as well. they said there seems to be some confusion abo

there is limited evidence on how well the astrazeneca vaccine works in the over—65s, but leading scientists are confident it will give strong protection. france, portugaland germany arejust some of the eu member states struggling to get hold of enough vaccine supplies. vaccinations are having to be postponed before the roll out has really begun. germany's health minister says the country's facing a shortage well into april and warned of at least 10 tough weeks ahead. jenny hill reports on the difficulties germany is facing. a waiting room without any patients. a vaccination centre without any vaccine. germany relied on the eu to place its orders, a decision which may have come at a cost. translation: we really feel it here. _ people keep asking us why we haven't been vaccinated yet. at the end of the day, these are political decisions which i have to accept, but i am looking forward to the time when we have enough vaccine and can get on with it. no tourists now for city guide teresia. immunity would bring life back to marburg's streets, restart the german economy. but just 2% of the populat

the eu is threatening legal action to force astrazeneca to hand over some doses made here. >> we can and will make -- will get doses of the vaccineseries of plants mentioned in the united kingdom. >> there is another twist. germany's faxing committee has said the astrazeneca jab should for now not be given to people age 65 and above. it has cited insufficient evidence of how effective it is in older people. the government here rejects that. p.m. johnson: our own authorities have made it clear that they think the astrazeneca vaccine is efficacious. they thi it is effective across all age groups and provides a good immune response across all age groups. >> there is limited evidence on how well the astrazeneca vaccine works in the over 65. leading scientists feel they are confident it will give strong protection. >> as you heard, a new report by germany's immunization commission says the oxford astrazeneca vaccine is not suitable for people over 65. on friday, the european medicines agency is expected to authorize the same vaccine across the eu. reporter: a waiting room without any patient. a vaccination center without any vaccine.

we also have the magenta vaccine and the astrazeneca vaccine -- moderna vaccine and the astrazeneca vaccinethere are also the vaccines coming out of china and russia. that although in my opinion do not have sufficiently transparent shared data come are being taken up by -- some low and middle income countries today. what we are seeing here is, they are still n having vaccines reach these counies in t quantities we would like toee. and the speed we are seeing in rich countries. but we are starting to see co vax, an international conglomerate -- ngo charity effort, to ensure eitable access to these vaccines, we see they are talking about scheduli some of these deliveries for this first round of vaccines in q1. things are improving, but not where we want them to be quite yet. brent: we have the eu, saying it is not receiving what it paid for and ordered. at the same time, you've got south africa's president today accusing wealthy countries of hoarding the vaccine for their own citizens. what is the truth here? >> the truth is, it's complicated. fundamentally, the truth, is -- the truth is, the

the oxford astrazeneca vaccine can be stored in the fridge. ted at -70. it will also play a key role in the global immunization. 3 billion doses are set to be distributed worldwide this year. fergus walshjoins me now. we all have so many questions about the virus. how effective is the oxford astrazeneca vexing, particularly after just one astrazeneca vexing, particularly afterjust one dose? a rough estimate, about 70% protection against covid disease. the highest —— perhaps most important, all those in trials we got one dose were protected against severe covid three weeks after they received that first dose. none of them required hospital treatment, so that would be a huge impact for them and for the nhs, and we'll begin to see that protective effect quite soon. how quickly are people going to be vaccinated? that is the big question. the sooner we can get to 2 million doses a week or more, the better. astrazeneca says it has 4 million doses waiting to 90, it has 4 million doses waiting to go, but they each have to be batch checked in batches of

the astrazeneca vaccine is grown in bioreactors. how complex the process is at this site in oxford. by contrast, there have been poor yields at the main european site in belgium. the eu is threatening legal action to force astrazeneca to hand over some doses made here. we can and will get doses of the vaccine from the series of plants which are mentioned in the contract and, therefore, also including those in the united kingdom. and there's another twist — germany's vaccine committee has said the astrazeneca jab should, for now, not be given to people aged 65 and above. it cited insufficient evidence in how effective it is in older people. the government here firmly rejects that. our own authorities have made it very clear that they think the oxford—astrazeneca vaccine is very good and efficacious. they think that it is effective across all age groups and provides a good immune response across all age groups. there is limited evidence on how well the astrazeneca vaccine works in the over—65s, but leading scientists here say they are

vaccinated. as we speak today, astrazeneca, who are hoping to get formal approvalfrom the eu on friday for their old the eu that they cannot supply what they thought they could in terms of the numbers of vaccines. the allocation was going to be something like 80 million, it's been cut to something under a0 million, which means ireland, you as a member state, are going to get 60% less of the astrazeneca vaccine than you were planning for. this presumably fundamentally changes the ambition you can have as to when you get your people vaccinated? well, if that pans out, of course that would change it fundamentally. as we speak, though, the european commission, i think, is engaged in intensive discussions with astrazeneca. there is a contract signed and money paid for this vaccine and the european union is entitled to receive it. i think that that message has been sent to astrazeneca loudly and clearly. it's not acceptable simply to change at the last minute just before approval and say, no, we can't give you the vaccine that you expected to have from march. 0n the other side of the coin, i know that

to to administer the oxford astrazeneca vaccine to scores to administer the oxford astrazeneca. it's exciting, you feel as if you are part of history, you feel like it is christmas time. it gives us hope for the future that we can help our patients and itjust gives us the light at the end of the tunnel. those who received it will need to maintain social distancing, they won't be fully protected, but there isa won't be fully protected, but there is a strong mood of optimism here. it's going to make a tremendous difference. it will make me feel more comfortable going up to the shops for shopping and things like that. but it's not all gone smoothly. queues of up to three hours were reported yesterday at this vaccination centre in north wales. the health board apologised saying the training of new vaccinators led to the delays. the health secretary matt hancock was due to see patients receiving the 0xford vaccine at a gp surgery in london but the delivery was delayed. supplies are being promised to practices across england. the prime minister said it was a national challenge like n

tonight, bad blood between the european union and a major coronavirus vaccine maker. astrazeneca says it is cutting back vexing deliveries to the eu, where the vaccine role it has been slow at best. we will be talking about the rollout across the eu. resigning with then i on rebuilding. italy's prime minister is set to step down with his government in crisis. when observers expect he will be back. plus, the u.s. senate receiving that article of impeachment against donald trump, which accuses him of inciting the storming of the u.s. capitol. we will gauge the mood and see if it makes sense to impeach an ex-president. plus, what to do about russia? the european union decides on nothing for now after russian critic alexey navalny and thousands of his supporters. ♪ i am brent goff. to our viewers on pbs in the united states and to all of you around the world, welcome. we begin with europe's coronavirus vaccine shot, the european union today lashing out at vaccine maker astrazeneca, accusing it of not delivering what it promised, vowing to blunt exports, and the company says it will d

also approved the vaccines from pfizer, moderna, and astrazeneca weeks before brussels, allowing it tounch its vaccine rollout earlier. some 7 million people in the u.k. have received a shot, roughly 10% of the population. by contrast in the eu, only 8 million have gotten the jab, barely 2% of residents. kate: the biden administration has confirmed it will actively reengage in talks on an international framework to digital giants. janet yellen told her french counterpart that she would return to the table abandoned by her predecessor last summer, in talks that are being overseen by the oecd. he welcomed the about-face in a phone call with yellen today. he said it would go some way to easing transatlantic trade tensions. the eu and u.s. are embroiled in a separate long-running trade spat over illegal subsidies to airbus and boeing. he said he hopes to travel to washington to seek a settlement. there is pressure on president biden to increase regulation of tech giants in terms of content and market share. antonio guterres saying he is particularly worried about the power of social media

almost 7.5 million across the united kingdom receive a first dose of either the pfizer or astrazeneca vaccinesinues with the european union, which is much slower off the mark in ordering and approving vaccines. the eu now wants access to some of the uk's supply of astrazeneca doses because of shortages on the continent. the eu regulator is expected to approve the astrazeneca vaccine today. meanwhile, in germany, where the pfizer vaccine is being used, a national vaccine committee has said that the astrazeneca jab for now not be given to people aged 65 and above because of insufficient evidence of how effective it is in older people. the government here has firmly rejected that. our own authorities have made it very clear that they think the oxford astrazeneca vaccine is very good and efficacious. they think that it is effective across all age groups and provides a good immune response across all age groups. the evidence _ across all age groups. the evidence of _ across all age groups. the evidence of how _ across all age groups. the evidence of how well - across all age groups. the evidence of

and the moderna vaccine _ astrazeneca vaccine and the moderna vaccine i_ astrazeneca vaccinecine effectiveness after _ vaccine. the vaccine effectiveness after the — vaccine. the vaccine effectiveness after the first dose has been reported by the manufacturers and others _ reported by the manufacturers and others as— reported by the manufacturers and others as being, which counts after day one. _ others as being, which counts after day one, the first dose to the second — day one, the first dose to the second dose, which is around 21 days _ second dose, which is around 21 days we — second dose, which is around 21 days. we know that vaccines do not work _ days. we know that vaccines do not work immediately. if i receive a vaccine — work immediately. if i receive a vaccine today i am not protected tomorrow — vaccine today i am not protected tomorrow. it takes about two weeks for the _ tomorrow. it takes about two weeks for the immune response to be generated before i can become protected. public health england have therefore taken the data from the vaccine — have therefore taken

— giving the astrazeneca vaccine and we're hoping to— giving the astrazeneca vaccine and we're hopingg the astrazeneca vaccine and we're hoping to do 1000 per- giving the astrazeneca vaccine and| we're hoping to do 1000 per week. giving the astrazeneca vaccine and i we're hoping to do 1000 per week. if we're hoping to do 1000 per week. it” this we're hoping to do 1000 per week. this does roll out to more and more pharmacies, you can see how quickly that adds up. but that is the plan? of course. here, we're the first pharmacy— of course. here, we're the first pharmacy to _ of course. here, we're the first pharmacy to start _ of course. here, we're the first pharmacy to start doing - of course. here, we're the first pharmacy to start doing it - of course. here, we're the first pharmacy to start doing it and i of course. here, we're the first i pharmacy to start doing it and after other— pharmacy to start doing it and after other pharmacies _ pharmacy to start doing it and after other pharmacies will— pharmacy to start doing it and after other pharmacies will be _ pharmacy to start doing

the oxford astrazeneca vaccine can be stored in the fridge. will also play a key role in the global immunisation. 3 billion doses are set to be distributed worldwide this year. fergus walsh is with me now. fergus walsh is with me nowm fergus walsh is with me now. it is important, on a day like today, when there is plenty to be really concerned and alarmed about, just to focus on the fact that there is hope, as the prime minister says — we could be in the final phase of this battle, even though it is a painful one and involves lots of sadness for lots of people. so when you listened to the prime minister earlier, going through the various categories of people, the kind of timetable for vaccination, what was your thoughts? what can you offer viewers in terms of guidance? well, i think what it shows is that there isa i think what it shows is that there is a way out, there is a path out of this pandemic which the vaccine will deliver, and every single person who gets immunised, it is one more chipping away of the power and strength of coronavirus.

but she had the astrazeneca vaccine, so you know, i really don't know what macron is saying here, or what he hopes to achieve by this.— to achieve by this. herriot, what ou think to achieve by this. herriot, what you think is _ to achieve by this. herriot, what you think is make _ to achieve by this. herriot, what you think is make you _ to achieve by this. herriot, what you think is make you read - to achieve by this. herriot, what you think is make you read his l you think is make you read his comments. a lot of anger over that, because the issue for some people is reticence. they don't want to get the vaccine. they are worried, and making comments like that, especially from someone in a position of power abuse does not help the situation. i position of power abuse does not help the situation.— help the situation. i think you're uuite help the situation. i think you're quite right- _ help the situation. i think you're quite right- it — help the situation. i think you're quite right. it also _ help the situation. i think you're quite right. it also comes - help the situation. i thin

she said best efforts only applied if astrazeneca could not produce the vaccine in the first place. r forjustice also speaking this morning on radio, saying that the way that the eu have worked, getting a contract together, he did not want to see a vaccine work. but he added may be the vaccine does —— the uk does want to see a vaccine war. it is becoming more hostile. the prime minister and public health england have defended the use of the oxford—astrazeneca jab, after germany recommended that it should only be given to people aged under 65. this morning, the head of germany's vaccine regulator rowed back from last night's stance, saying he expected the european union would approve the vaccine with a warning that the available data for older age groups was weaker. peter 0penshaw is professor of experimental medicine at imperial college london there isn't enough evidence on this. we have no evidence about its effectiveness from the oxford limb of the study. because originally the oxford investigators, quite rightly, 0xford investigators, quite rightly, decided to vaccinate fit, young

india regulators have approved astrazeneca's vaccine.ufactured and has been approved for restricted use as it is yet to complete his its phase 3 trials. bloomberg spoke exclusively to the company's founder on the logistical challenges ahead. it is a traditional technology. baby.like a newborn sensitivities. further see mutations, like we are seeing with this new variance in the u.k., would this particular treatment be able to deal with that? withere is a high chance the variant. have no data yet, but we are in the process. >> let's talk a little bit about efficacy of the vaccine here as well. where are you with it in terms of that, and what are you aiming for ultimately? one has to have efficacy to get approval. two,inly in phase one and .e get to almost 100% where we seat 98.5%. that is very significant. coming up on the program, control of the senate. that is what hinges on the outcome of the runoff in georgia. we will give you the latest on that, and trump's attempt to find votes in the state. this is bloomberg. ♪ ♪ annmarie: good mor

vaccines. also this lunchtime: the eu publishes the contract it signed with astrazeneca for millions of doses of covid vaccine, in a continunig row about a shortage. schools in wales could re—open to all pupils after half term — though the nationwide lockdown will continue. thousands of volunteers helping the nhs with the vaccine roll—out will be prioritised for a jab. and no glastonbury for us, but in new zealand music lovers can gather for concerts. we hear from what could be the biggest live act in the world at the moment. coming up in the sport on bbc news, a worry for tottenham and england after a double injury for harry kane. he only lasted half the match in their defeat to liverpool. good afternoon and welcome to the bbc news at one. a new coronavirus vaccine has been shown to be more than 89% effective in trials, and is the first that has proven to be effective against the new variant identified as circulating widely in the uk. the novavax jab is made by an american company, and it still has to be approved by medicines regulators, but the government has already ordered 60 million doses,

the first patient to be given the oxford—astrazeneca vaccine this morning at oxford university hospital brian pinker. he gave this reaction just after he received it. well, to be honest, i didn't feel a thing. brilliant, yeah. the vaccine means everything to me. i mean, to my mind, it's the only way of getting back to a bit of normal life. you know, this virus is terrible, isn't it? saturday, first i knew that i was going to be here today, yeah. very pleased, yeah, very pleased. the nurse who administered the firstjab, sam foster, spoke to our medical editor, fergus walsh, shortly afterwards and explained what it was like. it was a huge privilege. every single patient that we have vaccinated over the last couple of weeks has got their own personal story as to the difference it's going to make for them so no different in this morning with our first two patients. and what about you? have you been immunised yet? i have been immunised, yes. i was immunised, i've been working in the vaccine centre for a couple of weeks so i have received my vaccine. so it is obviously all systems go now. eve

first is the oxford university astrazeneca vaccine and the second one is the bharat biotech, which isrus to be recommended and after the approval, it became very clear because this one is very cost effective and it can be stored in a different way and it suits india and most importantly the astrazeneca vaccine is being made locally in india in the western part of india by an institute so this is easily available for india. there are questions over the second one, bharat biotech, there have been opposition politicians questioning about whether enough trials were conducted, what is the efficacy of this particular vaccine. we still don‘t know about that but the drug regulator was categorical in saying we will not approve anything without considering safety. and when does the roll—out of the vaccines begin and who is the priority, which population groups get it first? the government held a mass drill to check the gaps and india is a huge country, if they want to distribute and supply these vaccines, they need to have a system in place. and the government has already promised in the coming

how much pfizer. vaccine and how much astrazeneca vaccine _ vaccine and how much astrazeneca vaccine i give us a flow chart of when that is likely— give us a flow chart of when that is likely to _ give us a flow chart of when that is likely to be — give us a flow chart of when that is likely to be deployed _ give us a flow chart of when that is likely to be deployed over- give us a flow chart of when that is likely to be deployed over the - give us a flow chart of when that isj likely to be deployed over the next weeks? _ likely to be deployed over the next weeks? you — likely to be deployed over the next weeks? you did _ likely to be deployed over the next weeks? you did not— likely to be deployed over the next weeks? you did not give _ likely to be deployed over the next weeks? you did not give greg - likely to be deployed over the next| weeks? you did not give greg clark answers— weeks? you did not give greg clark answers to — weeks? you did not give greg clark answers to similar— weeks? you did not give greg clark answers to similar questions, - weeks? you did not give greg clark

the times reports the prime minister's confidence in the oxford—astrazeneca vaccine for over—65s — afteraccine — which is produced in belgium — could be blocked from entering the uk within days, after the eu warned it had to address shortages in its member states. and one of the most—read stories on the bbc news website today is that two—fifths of us are exercising less during this lockdown than in the first. a survey suggests we are watching more television and films this time around, with less time spent on volunteering and hobbies. charlie, are you exercising less? yes, it's interesting, i get out on my bike a little bit, so i try to do that as much as i can. this is a stoic, i pick up on this one from the telegraph, they are looking at some of the statistics. four in ten people apparently are now exercising less than they did in the first lockdown. a survey conducted by university college london, 70,000 people they talk to, quite a lot of people, and one third admit they have just people, and one third admit they havejust their people, and one third admit they have just their involve

an impact very soon and every single person who gets immunised, whether with the pfizer or astrazeneca vaccinee who are on the oxford astrazeneca vaccine trials, but now it is approved and the first batch is here they are just keeping people for a few minutes, monitoring them. by the end of the week people will be coming m, of the week people will be coming in, rolling up their sleeves, having the jab in, rolling up their sleeves, having thejab and, in in, rolling up their sleeves, having the jab and, in some places, drive—through centres. but in village halls, gp surgeries, racecourses, all sorts of places will be offering this and otherjabs and it will start to have an impact. but i don't think we should judge it on the first days or even the first week or so, but within a couple of weeks we will need to see this happening 1 million, 2 million doses per week if we are really to get the priority groups, the over 50s and especially the over 65 is and those with underlying health conditions immunised. we are going to come back to you in a couple of minutes but thank you very much indeed for tha

82—year—old man, dialysis patient brian pinker became the first person to receive the oxford—astrazeneca vaccinerward to celebrating his 48th wedding anniversary. the vaccine means everything to me. to my mind, it's the only way of getting back to a bit of normal life. you know, this virus is terrible, isn't it? sam foster administered the jab, which is seen as a crucial moment in the uk's fight against the coronavirus. it was a huge privilege. every single patient that we have vaccinated over the last couple of weeks have got their own personal stories to the difference it's going to make for them, so no different this morning with our first two patients. more than 500,000 doses are now being rolled out, starting with a small group of hospitals, including in oxford. a thumbs up from one of the scientists who helped develop the vaccine. it is a hugely proud moment. it is a testament to the efforts of the teams both here and around the world who have been working on the vaccine. but also, i think, especially important for all of those volunteers who came forward without really knowing whether thi

vaccines — so that it can monitor where they're being sent. it's the latest escalation in a deepening row between the eu and astrazeneca over supplies of the vaccinech is mostly produced here. today the eu's medicines regulator approved the use of the astrazeneca jab for everyone over the age of 18, though germany says it will still only give the jab to the under—65s. our brussels correspondent nick beake reports. throughout the week, this post—brexit battle between the eu and a british—based vaccine maker has been intensifying. european countries are demanding that astrazeneca delivers all the jabs they ordered — even if it means taking them from the uk supply. it all hangs on the contract the two sides signed, that's now been released, with parts blanked out. astrazeneca says it agreed to do its reasonable best. the eu insists it was a legally—binding promise. and so, it's now announced, if it doesn't get what it ordered, it could block covid vaccines leaving europe, heading for some countries, including the uk. we have to be very clear and we have said it many times before. we are not protecting ourselves against any specific country, and we ar

the oxford—astrazeneca vaccine has a the overall efficacy was 70 percent —— ranging from 62 to 90 percent russia's sputnik vaccine has a ninety—one—point—four percent efficacy —— that's according to the manufacturer. it's got emergency clearance in fifteen nations. and china's coronavac vaccine, developed by sinovac, has been cleared in six countries. it was found to be fifty—point—four percent effective in brazilian clinical trials. while the news of so many vaccines is encouraging, america's top infectious disease expert dr anthony fauci says we can't become complacent in fighting the virus. it is incentive to do what we have said all along, to vaccinate as many people as we can and as quickly as we possibly can. because mutations occur, because the virus has a playing field, as it were, to mutate. if you stop that and stop the replication, viruses cannot mutate if they do not replicate. anthony fauci's message comes as the south african variant of the virus has now spread to the us. scientists say its arrival could mark the beginning of an explosion in case numbers. at the same time, a

for the over 60 faves. _ astrazeneca vaccine for the over 60 fives. not _ astrazeneca vaccine them have chemists of the so-caiied _ of them have chemists of the so—called experts in the article are saying _ so—called experts in the article are saying it's — so—called experts in the article are saying it's 8% efficacy in the over 65 schema — saying it's 8% efficacy in the over 65 schema now astrazeneca this evening — 65 schema now astrazeneca this evening has launched a diatribe saying — evening has launched a diatribe saying that there is complete rubbish, _ saying that there is complete rubbish, and we will see over time but these — rubbish, and we will see over time but these things plant a huge seed of doubt _ but these things plant a huge seed of doubt in amongst people who are getting _ of doubt in amongst people who are getting that vaccine. of course they will and _ getting that vaccine. of course they will and it's— getting that vaccine. of course they will and it's been very concerning, and a _ will and it's been very concerning, and a iot— will and it's been very con

the oxford astrazeneca vaccine can be stored in the fridge. ich has to be to be transported at —70. it will also play a key role in the global immunisation. 3 billion doses are set to be distributed worldwide this year. stay with us on bbc news, still to come —inspiring children under covid lockdown — a leading children's author will tell us why her latest works deal with the pandemic. the japanese people are in mourning following the death of emperor hirohito. thousands converged on the imperial palace to pay their respects when it was announced he was dead. good grief — after half a century of delighting fans around the world, charlie brown and the rest of the gang are calling it quits. the singer paul simon starts his tour of south africa tomorrow in spite of protests and violence from some black activist groups. they say international artists should continue to boycott south africa until majority rule is established. around the world, people have been paying tribute to the iconic rock star, david bowie, who sold 140 million albums in a care

there is limited evidence on how well the astrazeneca vaccine works in the over—655, but leading scientistsll give strong protection. fergusjoins me now. more good news, another vaccine potentially novavax, how significant could that proved to be? , , ., ., , be? huge. this is already in the hands of the — be? huge. this is already in the hands of the medical— be? huge. this is already in the hands of the medical regulator, | be? huge. this is already in the - hands of the medical regulator, the mra chart —— the mhra, they began a rolling review of the uk trials of the novavax vaccine earlier this month and if, and they have to prove it's safe and effective, if they approve it then it will be produced here and it will put rocket boosters under the uk vaccine programme which is already outstripping most of europe. so it's brilliant news and the fact that it's effective, highly effective against the uk variant and less so effective but still effective against the south african one, fantastic news. you effective against the south african one, fantastic news.— effective against the south africa

and of course when it came to the astrazeneca vaccine being rolled out today on the 530,000 of them availablealthough the government is promising swift roll—out of accessing —— of that vaccine is a huge margin of error, negative factor into that the time like that you have in terms of the vaccine and how long it actually ta kes to the vaccine and how long it actually takes to give you the immunity and again there's been a great concern around whether you need that second dose of the vaccine and whether or not... because we running out of time what it jump not... because we running out of time what itjump into ourfederal newspaper, the daily mail whose headline is it's back to square one. i almost thought if i did not get to or papers i was difficult to bring in from march 2020 and see if either of you noticed. it almost feels like march 2020 apart from the daffodils. does that feel like march last year? it feels a whole lot worse. that is just the reality. and i think one thing that is making people feel all the more angry and frustrated, and pessimistic is this tendency as caroline has said

the oxford astrazeneca vaccine can be stored in a fridge — a key advantage over the pfizer vaccine, whichay a key role in the global immunisation. 3 billion doses are set to be distributed worldwide this year. now other news, and two democrat congressmen have called on the fbi to investigate donald trump's phone call to the top election official in georgia. they say the president's request for enough votes to be found to overturnjoe biden‘s victory in the state broke election law. the demand came to light when the washington post released a recording of the hour—long conversation — as our north america editorjon sopel reports. are you ready to show america that georgia's a red state? in georgia, there is intense campaigning ahead of senate elections tomorrow, which will determine whether it's the republicans or democrats who control the opera house in washington. say vote! vote! but over the weekend, there was a very different type of lobbying going on, donald trump trying to persuade a republican state official over the phone to rewrite the certified results of last november's election a